Integer Holdings (ITGR) Net Cash Flow Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Integer Holdings | 3.11 Bn | 3.11 Bn | 109.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 14.71% |
| Dec 31, 2025 | 3.84% |
| Sep 26, 2025 | 18.40% |
| Jun 27, 2025 | -15.51% |
| Mar 28, 2025 | -21.03% |
| Dec 31, 2024 | 81.66% |
| Sep 27, 2024 | 32.48% |
| Jun 28, 2024 | -38.19% |
| Mar 29, 2024 | 28.30% |
| Dec 31, 2023 | -42.83% |
| Sep 29, 2023 | -30.90% |
| Jun 30, 2023 | 28.85% |
| Mar 31, 2023 | 24.27% |
| Dec 31, 2022 | 99.44% |
| Sep 30, 2022 | 11.59% |
| Jul 1, 2022 | 21.87% |
| Apr 1, 2022 | 21.48% |
| Dec 31, 2021 | -24.60% |
| Oct 1, 2021 | -21.62% |
| Jul 2, 2021 | 16.19% |
| Apr 2, 2021 | 6.68% |
| Dec 31, 2020 | -20.35% |
| Apr 3, 2020 | 35.73% |
| Sep 27, 2019 | -15.92% |
| Jun 28, 2019 | -27.63% |
| Mar 29, 2019 | -44.44% |
| Dec 28, 2018 | -42.63% |
| Sep 28, 2018 | 21.48% |
| Jun 29, 2018 | -186.76% |
| Mar 30, 2018 | -8.55% |
| Dec 29, 2017 | -53.68% |
| Sep 29, 2017 | -60.47% |
| Jun 30, 2017 | -48.69% |
| Mar 31, 2017 | 15.92% |
| Dec 30, 2016 | 30.60% |
| Sep 30, 2016 | 14.55% |
| Jul 1, 2016 | -2.31% |
| Apr 1, 2016 | -24.81% |
| Jan 1, 2016 | 0.62% |